Cause of hospitalization in patients with human immunodeficiency virus infection in a rural area. Role of chronic liver disease;Motivo de ingreso en pacientes infectados por el virus de la inmunodeficiencia humana en un área rural. Papel de la hepatopatía crónica

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 22, Issue 3, 2004, Pages 138-141

  Rodríguez Vidigal, Francisco F ^a,b   Habernau, Alicia ^a  

^a Departamento de Medicina Interna   (Spain)

^b Servicio de Medicina Interna   (Spain)

Author keywords

AIDS; Hepatitis C virus; HIV; Hospitalization; Opportunistic infection

Indexed keywords

CD4 ANTIGEN;

ADULT; ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LENGTH OF STAY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; RETROSPECTIVE STUDY; RURAL AREA;

EID: 11144357123     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13058021     Document Type: Article

References (17)

1. Palella F, Delaney K, Moorman A, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced HIV infection. N Engl J Med 1998;38:853-60.
2. Hoggs RS, Heath KV, Yip B, Craib KJ, O'Shaughnessy MV, Schechter MT, et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA 1998;279;450-4.
3. Gálvez C, Blanco F, Del Amo J, Díaz M, Soriano V, González J. Efectos del tratamiento antirretrovírico y de la profilaxis para enfermedades oportunistas en la supervivencia de los pacientes con sida. Rev Clin Esp 2000;200:187-92.
4. Soriano V, García-Samaniego J, Bravo R, Valencia E, Laguna F, De Pauplana M, et al. Morbilidad y mortalidad asociadas con hepatopatía crónica viral en pacientes infectados con el virus de la inmunodeficiencia humana. Med Clin (Barc) 1995;104:641-4.
5. Macías J, Pineda JA, Leal M, Abad MA, Garcia-Pesquera F, Delgado J, et al. Influence of hepatitis C virus infection on the mortality of antiretroviral-trated patients with HIV disease. Eur J Clin Microbiol Infect Dis 1998;17:167-70.
6. Geffray L, Rosenthal E, Cacoub P, Perronne C, Veyssier P, Raguin G, et al. 1977 mortality rate in HIV-infected patients presenting with he'patitis C cirrhosis. Results of the GERMIVC multicenter survey conducted in French departments of internal medicina or infectious disease. Rev Med Interne 1999;20:1082-7.
7. Staples CT Jr, Rimland D, Dudas D. Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affaisr Medical Center) Cohort Study (HAVACS): The effect of coinfection on survival. Clin Infect Dis 1999;29:150-4.
8. Greub G, Ledergerber B, Battegay M, Grob P, Perrin L, Furrer H, et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: The Swiss HIV Cohort Study. Lancet 2000;356:1800-5.
9. Soriano V, Kirk O, Antunes F, et al. The influence of hepatitis C on the prognosis of HIV. The EuroSIDA Study. XIII Int AIDS Conf, Durban, July 2000 [Abstract ThOrB655].
10. Bica I, McGovern B, Dhar R, Stone D, McGowan K, Scheib R, et al. Increasing mortality due to end-satge liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 2001;32:492-7.
11. Monga HK, Rodríguez-Barradas MC, Breaux K, Khattak K, Troisi CL, Vélez M, et al. Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection. Clin Infect Dis 2001;33:240-7.
12. Plan Nacional sobre el Sida. Encuesta hospitalaria de pacientes VIH/Sida. Análisis de la evolución 1995-2000. Madrid, 2001.
13. Álvarez MM. Informe sobre el sida en Extremadura a fecha 31 de diciembre de 2000. Boletín Epidemiológico de Extremadura 2001;2:1-3.
14. Torres R, Barr M. Impact of combination therapy for HIV infection on inpatients census. N Engl J Med 1997;336:1531-2.
15. Paul S, Gilbert HM, Ziecheck W, Jacobs J, Sepkowitz KA. The impact of potent antiretroviral therapy on the characteristics of hospitalized patients with HIV infection. AIDS 1999;13:415-8.
16. Cacoub P, Geffray L, Rosenthal E, Perronne C, Veyssier P, Raguin G. Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French Departments of Internal Medicine/Infectious Diseases, in 1995 and 1997. Clin Infect Dis 2001;32:1207-14.
17. rd, Dickson ER. Outcome of hospital care of liver disease associated with hepatitis C in the United States. Hepatology 2001;33:201-6.